Anika Therapeutics, Inc. (ANIK) — Gross Profit
| Fiscal Year | Gross Profit | Change YoY |
|---|---|---|
| 2025 | $63.81M | -16.0% |
| 2024 | $76.00M | -7.9% |
| 2023 | $82.53M | +12.7% |
| 2022 | $73.22M | -11.7% |
| 2021 | $82.94M | +20.2% |
| 2020 | $69.03M | -19.6% |
| 2019 | $85.86M | +15.6% |
| 2018 | $74.28M | — |
| Fiscal Year | Gross Profit | Change YoY |
|---|---|---|
| 2025 | $63.81M | -16.0% |
| 2024 | $76.00M | -7.9% |
| 2023 | $82.53M | +12.7% |
| 2022 | $73.22M | -11.7% |
| 2021 | $82.94M | +20.2% |
| 2020 | $69.03M | -19.6% |
| 2019 | $85.86M | +15.6% |
| 2018 | $74.28M | — |